| HOME >> MEDICINE >> TECHNOLOGY |
by Product Segment - Bare Metal and Drug Eluting Stent
Markets Independently Analyzed with Annual Sales in US$
Million for years 2003 through 2008 (includes corresponding
Graph/Chart) 167
Table 112: Rest of World Historic Review for Coronary Stents
by Product Segment - Bare Metal and Drug Eluting Stent
Markets Independently Analyzed with Annual Sales in Thousand
Units for years 2003 through 2008 (includes corresponding
Graph/Chart) 168
Table 113: Rest of World 15-Year Perspective for Coronary
Stents by Product Segment - Percentage Breakdown of Dollar
Sales for Bare Metal Stents and Drug Eluting Stents Markets
for years 2003, 2010 & 2017 (includes corresponding
Graph/Chart) 169
Table 114: Rest of World 15-Year Perspective for Coronary
Stents by Product Segment - Percentage Breakdown of Unit
Sales for Bare Metal Stents and Drug Eluting Stents Markets
for years 2003, 2010 & 2017 (includes corresponding
Graph/Chart) 170
COMPETITIVE LANDSCAPE
Total Companies Profiled: 53 (including Divisions/Subsidiaries - 62)
------------------------------------------
Region/Country Players
------------------------------------------
The United States 34
Canada 1
Japan 3
Europe 15
France 1
Germany 5
The United Kingdom 1
Italy 1
Spain 1
Rest of Europe 6
Asia-Pacific (Excluding Japan) 5
Middle-East 2
Africa 2
------------------------------------------
To order this report:
Cardiovascular Devices Industry: Global Coronary Stents Industry
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |